|
ChatGPT for Clinicians, Denials, and GLP-1 Side Effects
April 23, 2026
|
|
|
|
|
Together with
|
|
|
|
“We are past the event horizon; the takeoff has started. Humanity is close to building digital superintelligence, and at least so far it’s much less weird than it seems like it should be.”
|
|
OpenAI CEO Sam Altman
|
|
|
|
OpenAI is doubling down on providers, and this time around it’s going direct-to-docs with ChatGPT for Clinicians.
ChatGPT-5.4, but for clinicians. OpenAI’s medically-tuned version of ChatGPT uses the same engine as GPT-5.4, with specialized training to optimize it for clinical workflows and administrative tasks.
- Better yet, it’s free for any verified physician, NP, PA, or pharmacist in the U.S.
ChatGPT for Clinicians includes:
- Access to GPT-5.4 and OpenAI’s other models (increased limits for clinical tasks).
- Skills for repeatable workflows (like drafting referral letters and patient instructions).
- Clinical search based on “millions of peer-reviewed sources” (details were sparse).
- Optional support for HIPAA compliance (through a BAA for eligible accounts).
ChatGPT for Clinicians doesn’t include:
- Connectors to the CMS Coverage Database, NPI Registry, or ICD-10. Not impossible.
- Broader platform advantages like integrated drug information or telehealth.
- Evidence from big name partners that’s contextualized to the encounter.
- HIPAA compliance out-of-the-box.
All that said, the performance talks. ChatGPT for Clinicians was launched alongside HealthBench Professional, OpenAI’s new benchmark built from real clinical conversations.
- It grades models on chat tasks across three use cases (care consults, documentation, and medical research), with physician-authored scenarios and rubrics, as well as scoring designed to reflect real-world performance.
- As you might expect, OpenAI’s new tool did great on OpenAI’s new benchmark. ChatGPT for Clinicians outperformed Claude Opus 4.7, Gemini 3.1 Pro, and even specialty-matched physicians with unlimited time and web access.
What happened to ChatGPT for Healthcare? OpenAI launched ChatGPT for Healthcare just a few short months ago to help health systems with enterprise-wide deployments, but now it’s taking “the next step” by bringing ChatGPT straight to individual clinicians so that “AGI benefits all of humanity.”
The Takeaway
Whether OpenAI is pursuing an altruistic mission or hedging slow progress in the enterprise arena, millions of clinicians already use ChatGPT to support their care, and now they have a fine-tuned version that won’t break the bank.
|
|
Unlock Accurate Transcription With Medical Mode
Unlocking accurate transcription of even the most complex medical terminology is now as easy as adding a single line of code. AssemblyAI’s new Medical Mode eliminates errors on the words that matter most – medicine names, dosages, and clinical diagnoses – so that you can ship solutions that perform when accuracy isn’t optional. Start building with Medical Mode today.
|
|
Abridge & Availity Redefine Payer-Provider Synergy
Abridge is teaming up with Availity to redefine payer-provider synergy at the point of conversation. The collaboration aligns Abridge’s evidence-aware intelligence with Availity’s real-time health information network to create a first-of-its-kind prior authorization experience, with a shared understanding between patients, providers, and payers. Find out how Abridge and Availity are extending conversational intelligence across the revenue cycle.
|
|
- Big Week for Peptides: The peptide market didn’t waste any time kicking off its big boom following last week’s news that the FDA is considering easing up restrictions. Established players like Hims & Hers saw shares skyrocket 50% after announcing that they’re expanding the product line, and new players like Protocole emerged from stealth with $6M to build physician-supervised peptide protocols. Noom also scooped up Tailor Made Compounding to push into the category, and Superpower debuted its own peptide platform to capitalize on the moment.
- Denial Reversals On the Rise: A study in JAMA Internal Medicine showed that patients and clinicians have been getting better at overturning claim denials. Researchers analyzed 51k cases in New York between 2019 and 2025, finding that the percentage of payor decisions overturned by external reviews climbed from 38% to 52.5% over the period. The rates varied widely by treatment category, with the most successful appeals in home healthcare (80%) and substance use services (61%). The most common reasons for denials included evergreen favorites like human error and ambiguous coverage rules.
- Amperos Series A: The denial stats might start looking even better after Amperos Health landed $16M of Series A funding to help providers resolve denials five times faster and cut denial rates by 70%. Amperos is reportedly the first revenue recovery partner capable of working denials end-to-end entirely with AI, although it also supports its agents with a team of subject matter experts to help with complex and difficult-to-recover claims.
- Hidden Side Effects of GLP-1s: A study in Nature Health combed through over 400k Reddit posts to uncover GLP-1 side effects that clinical trials might be missing. Just over 43% of Reddit users who self-reported that they’re taking a GLP-1 also mentioned a side effect, most commonly nausea (36.9%), fatigue (16.7%), and vomiting (16.3%). Reproductive symptoms like menstrual irregularities emerged as an unrecognized potential effect, as well as temperature-related complaints such as chills and hot flushes. The research lands just as the White House reverses course on Medicare coverage for weight loss drugs
- Coral Raises $12M: AI automation platform Coral hauled in $12.5M to automate healthcare’s back office “by working with, not against, the fax machine.” Instead of asking its customers to rebuild their infrastructure, Coral connects to existing EHRs, fax lines, and payor portals, then helps automate every workflow that touches them. The focus so far has been supporting areas like specialized intake and fax processing for DME suppliers, infusion centers, and radiology practices.
- Ambience Roadmap: Ambience Healthcare shared a glimpse of its product roadmap as it continues growing beyond its roots in ambient documentation. The roadmap emphasizes “redesign over optimization” across five domains: clinical workflows, revenue integrity, patient experience, care orchestration, and clinical research. Health system partners joined Ambience on stage at its inaugural Apex Summit to showcase how they’re bringing the roadmap to life through collaborations like Project Orchestra (a care orchestration initiative with Cleveland Clinic) and Project Archimedes (a research-focused effort with Mayo Clinic).
- LLMs for Health Queries: A new study in Nature wrapped some numbers around how people are using general-purpose LLMs to guide their health. The analysis of 500k conversations with Microsoft Copilot revealed that 40% of health-related conversations were seeking general health information as opposed to medical advice, while just one in five health conversations involved personal symptom assessments or condition discussions. The authors also pointed out that AI is increasingly relied on as a caregiving tool, with one in seven health queries involving someone other than the user.
- Hippocratic Voice Agents: Hippocratic AI rolled out a pair of new voice AI agents for intake and inpatient nursing. AI Front Door is an “omni-topic” agent that lets patients schedule an appointment, ask about lab results, or address a billing issue in a single conversation. Nurse Co-Pilot allows nurses to select a patient and workflow (e.g. education or medication adherence) then have a voice agent call them directly, with a structured clinical summary and full transcript written back to the EHR automatically.
- CB State of Digital Health: CB Insights’ State of Digital Health Q1’26 confirmed the funding momentum in Rock Health’s overview, while also adding some color to the M&A picture. Funding rose to $7.4B in Q1, hitting the highest total seen since 2022. CB highlighted DeepHealth’s $269M acquisition of Gleamer to show what drives premium valuations: broad adoption (700+ hospital contracts across 44 countries) and meaningful revenue ($30M projected for 2026). By contrast, Oxipit achieved the world’s first CE Class IIb certification for fully autonomous chest X-ray interpretation, and generated just $27.6K in revenue in 2024.
- Patients Struggle With Finances: Cedar’s 2026 Trends In Patient Payments report found that 40% of collections now come from patients without health coverage, up 54% in the past three years. A major contributing factor is the 65% increase in high-deductible health plan enrollment over the last decade, and the forecast doesn’t look much brighter. Cedar notes that 20M people are experiencing premium hikes following the end of ACA subsidies, while another 10M are expected to lose Medicaid coverage due to new work requirements.
|
|
Privia Accelerates VBC Success With Navina
How do you give physicians new AI tools to accelerate VBC without slowing them down? Privia Health found its answer with Navina. They co-designed an under-one-hour training program that onboarded 800+ clinicians in the first year, driving 87% weekly active usage while providing clearer visibility into their patient panels. Read the full case study to see what it takes to make adoption stick and outcomes follow.
|
|
State of Payor Enrollment and Credentialing
AI is changing the way that healthcare leaders tackle provider network management. Medallion’s latest report breaks down the biggest challenges, emerging trends, and how automation is transforming the landscape. Get the insights you need – read the full report today.
|
|
- The Perfect Moment for Digital Health: With expanded support for remote care, digital health is positioned to play a central role in value-based models. Check out Withings’ latest overview to learn how connected technologies can help reduce preventable events while improving care quality and efficiency.
- Virtual-First, Local Always: The humans of healthcare can get lost in the background at conferences full of robo-docs and AI assistants, but deep personal connections are just as key as new technologies for driving better outcomes. Find out how Ovatient is keeping care “virtual-first, local always” in Digital Health Wire’s rapid-fire interview from the ViVE exhibit hall.
- The AI Hardware Built for Clinical Work: Phones were never meant to be propped on a desk for a 12-hour clinical day. Heidi Remote transcribes patient sessions offline, stores them securely on-device, and syncs to Heidi whenever you’re in range. Just clip on and get to work with the Heidi Remote.
- Shape Health AI at DHAI 2026: Mark your calendars. The Digital Health & AI Innovation Summit is bringing together AI leaders from across the industry for a live event in Boston on June 8-9th. This year’s agenda is packed with 150+ speakers and content curated specifically for the pioneers shaping health AI. Reserve your spot for DHAI 2026 today.
|
|
|
|
|
